News Conference News ACC 2024 Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It Michael O'Riordan March 27, 2024
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News ACC 2020 Better QoL After MitraClip Plus Fewer Deaths, HF Hospitalizations: COAPT Shelley Wood March 17, 2020
News Conference News ACC 2019 PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital Michael O'Riordan March 25, 2019
News Conference News ACC 2018 Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3 Shelley Wood March 16, 2018